Zantac Cancer Problems Constitute “Sinister” Public Health Fraud By Drug Makers
A Zantac lawsuit claims the manufacturers of the heartburn drug committed fraud by failing to warn about the presence and risks of NDMA.…
«
»
A Zantac lawsuit claims the manufacturers of the heartburn drug committed fraud by failing to warn about the presence and risks of NDMA.…
Three claims have been chosen to serve as potential Taxotere bellwether trial cases in August 2020.
…
In September 2019, the FDA warned that the popular heartburn drug Zantac may contain cancer-causing impurities. These same chemicals have been linked to an increased risk of colorectal cancer, stomach cancer, liver cancer and other health problems.…
A Zantac lawsuit blames the recalled heartburn drug for a man’s bladder cancer diagnosis.…
A joint lawsuit filed by nine plaintiffs calls recent Zantac recalls over NDMA contamination one of the biggest fraud cases in U.S. history, which may have left many Americans at higher risk of cancer.…
A Zantac class action lawsuit calls for the manufacturers to pay back everyone who has bought the over-the-counter drug since January 2010, and to require warning labels indicating the presence of high levels of NDMA, a cancer-causing agent.…
The first Taxotere bellwether lawsuit has ended in a defense verdict over claims that the chemotherapy drug caused permanent hair loss.…
The makers of Zantac face a class action lawsuit from plaintiffs in California, who say they knew or should have known the heartburn drug contained high levels of NDMA; which has been linked to an increased cancer risk.
…
The federal judge overseeing Taxotere hair loss litigation has set a schedule leading to the first bellwether trial in September.…
A federal judge has delayed the first Taxotere bellwether trial over claims of permanent hair loss until September.…